Improved targeting of platinum chemotherapeutics
- 1 January 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (2), 291-297
- https://doi.org/10.1016/j.ejca.2003.09.022
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implicationsInternational Immunopharmacology, 2002
- Vascular Morphogenesis and Remodeling in a Human Tumor XenograftCirculation Research, 2001
- Water soluble polymers in tumor targeted deliveryJournal of Controlled Release, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of actionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinomaInternational Journal of Cancer, 2000
- Preclinical Perspectives on Platinum ResistanceDrugs, 2000
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjugate Chemistry, 1992
- Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinasesBioscience Reports, 1982